Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

The Health Effect of Psychostimulants: A Literature Review.

Favrod-Coune T, Broers B.

Pharmaceuticals (Basel). 2010 Jul 22;3(7):2333-2361. Review.

2.

Cocaine-like discriminative stimulus effects of amphetamine, cathinone, methamphetamine, and their 3,4-methylenedioxy analogs in male rhesus monkeys.

Smith DA, Blough BE, Banks ML.

Psychopharmacology (Berl). 2017 Jan;234(1):117-127. doi: 10.1007/s00213-016-4444-1.

PMID:
27709249
3.

Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation.

Amador A, Huitron-Resendiz S, Roberts AJ, Kamenecka TM, Solt LA, Burris TP.

PLoS One. 2016 Sep 7;11(9):e0162452. doi: 10.1371/journal.pone.0162452.

4.

Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies.

Althobaiti YS, Sari Y.

J Addict Res Ther. 2016 Jun;7(3). pii: 281.

5.

The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals.

Shorter D, Nielsen DA, Hamon SC, Nielsen EM, Kosten TR, Newton TF, De La Garza R 2nd.

Pharmacogenet Genomics. 2016 Sep;26(9):428-35. doi: 10.1097/FPC.0000000000000234.

PMID:
27379509
6.

Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.

Ruoff C, Swick TJ, Doekel R, Emsellem HA, Feldman NT, Rosenberg R, Bream G, Khayrallah MA, Lu Y, Black J.

Sleep. 2016 Jul 1;39(7):1379-87. doi: 10.5665/sleep.5968.

7.

Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.

Marks KR, Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR.

J Clin Psychopharmacol. 2016 Jun;36(3):213-21. doi: 10.1097/JCP.0000000000000488.

PMID:
27043121
8.

Enhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry.

Hoffman AF, Spivak CE, Lupica CR.

ACS Chem Neurosci. 2016 Jun 15;7(6):700-9. doi: 10.1021/acschemneuro.5b00277.

PMID:
27018734
9.

Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis).

Ballesta S, Reymond G, Pozzobon M, Duhamel JR.

PLoS One. 2016 Feb 3;11(2):e0147136. doi: 10.1371/journal.pone.0147136.

10.

Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys.

Kohut SJ, Bergman J, Blough BE.

Psychopharmacology (Berl). 2016 Mar;233(6):1067-75. doi: 10.1007/s00213-015-4186-5.

PMID:
26713332
11.

Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.

Suyama JA, Sakloth F, Kolanos R, Glennon RA, Lazenka MF, Negus SS, Banks ML.

J Pharmacol Exp Ther. 2016 Jan;356(1):182-90. doi: 10.1124/jpet.115.229559.

12.

Classic Studies on the Interaction of Cocaine and the Dopamine Transporter.

Verma V.

Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):227-38. doi: 10.9758/cpn.2015.13.3.227.

13.

Greater hunger and less restraint predict weight loss success with phentermine treatment.

Thomas EA, Mcnair B, Bechtell JL, Ferland A, Cornier MA, Eckel RH.

Obesity (Silver Spring). 2016 Jan;24(1):37-43. doi: 10.1002/oby.21244.

14.

Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue.

Ayala-Lopez N, Jackson WF, Burnett R, Wilson JN, Thompson JM, Watts SW.

Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1904-14. doi: 10.1152/ajpheart.00308.2015.

15.

Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.

Kirkpatrick MG, Goldenson NI, Kapadia N, Kahler CW, de Wit H, Swift RM, McGeary JE, Sussman S, Leventhal AM.

Psychopharmacology (Berl). 2016 Jan;233(1):89-97. doi: 10.1007/s00213-015-4091-y.

16.

The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction.

Zaniewska M, Filip M, Przegalinski E.

Curr Neuropharmacol. 2015;13(3):407-18. Review.

17.
18.

Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms.

dela Peña I, Gevorkiana R, Shi WX.

Eur J Pharmacol. 2015 Oct 5;764:562-70. doi: 10.1016/j.ejphar.2015.07.044. Review.

19.

The rise (and fall?) of drug discrimination research.

McMahon LR.

Drug Alcohol Depend. 2015 Jun 1;151:284-8. No abstract available.

20.

Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.

Dürsteler KM, Berger EM, Strasser J, Caflisch C, Mutschler J, Herdener M, Vogel M.

Subst Abuse Rehabil. 2015 Jun 17;6:61-74. doi: 10.2147/SAR.S50807. Review.

Items per page

Supplemental Content

Support Center